Abstract: Eyelid illumination systems and methods for imaging meibomian glands for meibomian gland analysis are disclosed. In one embodiment, a patient's eyelid is IR trans-illuminated with an infrared (IR) light. A trans-illumination image of the patient's eyelid is captured showing meibomian glands in dark outlined areas, whereas non-gland material is shown in light areas. This provides a high contrast image of the meibomian glands that is X-ray like. The lid trans-illumination image of the meibomian glands can be analyzed to determine to diagnose the meibomian glands in the patient's eyelid. The eyelid may be trans-illuminated by a lid-flipping device configured to grasp and flip the eyelid for imaging the interior surface of the eyelid. Also, an IR surface meibography image of the meibomian glands may also be captured and combined with the trans-illumination image of the meibomian glands to provide a higher contrast image of the meibomian glands.

Abstract: In a blood information measuring apparatus, a plurality of types of light of a superficial layer wavelength set, a middle layer wavelength set, and a deep layer wavelength set are successively applied to a detected hypoxic region. A CCD captures an image under the light of each wavelength set, and an oxygen saturation image is produced independently from one wavelength set to another. A wavelength set determination section creates a histogram of each oxygen saturation image. The wavelength set determination section chooses one of the wavelength sets corresponding to the histogram having a maximum variance as an actual imaging wavelength set. Actual imaging operation is performed using the actual imaging wavelength set, and an oxygen saturation level of each pixel is calculated. The oxygen saturation level is reflected in the image, and the image is displayed on a monitor.

Abstract: In a blood information acquisition mode for obtaining an oxygen saturation level of hemoglobin in a blood vessel, preliminary imaging and main imaging are performed. In the preliminary imaging, a normal internal body part is imaged. A blood information calculation section calculates an oxygen saturation level of each pixel. A changing section corrects standard reference data in accordance with a difference between an average of the oxygen saturation levels obtained in the preliminary imaging and a predetermined standard value of the oxygen saturation level. In the subsequent main imaging, corrected reference data is used to calculate an oxygen saturation level of each pixel corresponding to an internal body part being observed.

Abstract: A radiation detector (16) having a first detector layer (24) and a second detector layer (26) encircles an examination region (14). Detectors of the first layer include scintillators (72) and light detectors (74), such as avalanche photodiodes. The detectors of the second detector layer (26) include scintillators (62) and optical detectors (64). The scintillators (72) of the first layer have a smaller cross-section than the scintillators (62) of the second layers. A group, e.g., nine, of the first layer scintillators (72) overlay each second group scintillator (62). In a CT mode, detectors of the first layer detect transmission radiation to generate a CT image with a relatively high resolution and the detectors of the second layer detect PET or SPECT radiation to generate nuclear data for reconstruction into a lower resolution emission image. Because the detectors of the first and second layers are aligned, the transmission and emission images are inherently aligned.

Abstract: Methods, medical devices, and magnetic resonance imaging (MRI) systems are provided. A patient implanted with a medical device is exposed to a time-varying magnetic field having a signature, thereby inducing mechanical vibrations in at least one component of the medical device. A vibrational characteristic of the mechanical vibrations induced in the component(s) is detected. The vibrational characteristic is analyzed, and the signature of the magnetic field is identified based on the analyzed vibrational characteristic. The medical device is automatically switched from a first operational mode to a second operational mode when the signature is identified.

Abstract: An intracorporeal marker system includes a tissue marker pellet comprised of a polysaccharide material. The intracorporeal marker system may also include a fibrous marker of bioabsorbable fibers. In one embodiment, for example, an outer layer of bioabsorbable fibers is disposed around at least part of an inner core of bioabsorbable fibers.

Abstract: A photoacoustic wave measuring apparatus, having: a probe including a plurality of devices which detect an acoustic wave generated by irradiating light onto an object; and a signal processor which acquires information about the object on the basis of an acoustic wave received by the devices, wherein the light is irradiated onto the object from the probe side; the probe includes: bright-field devices having a view angle covering a bright-field illumination area, which is an area where the light is irradiated, on the probe-side surface of the object; and dark-field devices having a field of view which does not cover the bright-field illumination area; and the signal processor uses an acoustic wave received by the dark-field devices when acquiring information about the object on the basis of a acoustic wave received before a predetermined time period is elapsed since the irradiation of light onto the object.

Abstract: A system and method for detecting vascular contamination by surgical anesthetic using non-invasive IR spectrophotometry. One embodiment is a method for operating an instrument such as an enhanced pulse oximeter to monitor a patient receiving local anesthetic marked with dye that absorbs infrared light. Light is applied to and detected from tissue of the patient. A signal representative of the detected light is processed to derive patient oxygenation information. The detected light is also processed to derive information representative of the presence of the dye-marked anesthetic. The oxygenation information and the information representative of the presence of anesthetic are displayed. The oxygenation monitoring and display and the anesthetic monitoring and display can occur separately or concurrently. Fluorescing dyes and fluorescence detection approaches are used for anesthetic detection in some embodiments.

Abstract: A system and method is disclosed that can be used to track and navigate an instrument relative to a patient. The system can include an electromagnetic tracking system to track an electromagnetic stimulation probe, such as a transcranial magnetic stimulation probe. The system can, according to various embodiments, provide a tracking device on the probe, track the coil of the probe, provide a field relative to the probe, and determine the position of the patient based upon the field produced by the probe.

Abstract: A method for mapping T1 in myocardium includes selecting a recovery delay from EKG signal data; imposing a saturation pulse on the myocardium; waiting the recovery delay; and acquiring bSSFP data after the recovery delay.

Abstract: The wound assessing method and system of the present teachings provide a convenient, quantitative mechanism for diabetic foot ulcer assessment.

Abstract: Systems and methods for imaging ear tissue include: directing illumination radiation to pass through an intact biological structure and be incident on ear tissue that does not include an exogenous fluorophore, at a plurality of locations, the illumination radiation including a plurality of light pulses each having a temporal duration of 500 femtoseconds or less; for each one of the plurality of locations, using a detector to detect radiation emitted from the location that passes through the intact biological structure; and forming an image of the tissue based on the detected radiation at each of the plurality of locations, where the emitted radiation corresponds to endogenous two-photon fluorescence of the tissue.

Abstract: A compact, on-airway, respiratory gas analyzer for performing pulmonary function tests incorporates an IR spectroscopy light guide having a curved, rather than linear, sample chamber that lies transverse to a direction of respiratory gas flow. Cooperating with the sample chamber is an impact plate that functions to steer respiratory and test gases impinging on the impact plate into the curved sample chamber. A source of IR energy is at one end of the sample chamber and an electro-optical sensor responsive to IR energy is disposed at an opposite end of the chamber. The respiratory gas analyzer also includes gas flow paths and valving for carrying out lung capacity and lung diffusion tests.

Abstract: The wound assessing method and system provide a convenient, quantitative mechanism for diabetic foot ulcer assessment.

Abstract: A compact, on-airway, respiratory gas analyzer for performing pulmonary function tests incorporates an IR spectroscopy light guide having a curved, rather than linear, sample chamber that lies transverse to a direction of respiratory gas flow. Cooperating with the sample chamber is an impact plate that functions to steer respiratory and test gases impinging on the impact plate into the curved sample chamber. A source of IR energy is at one end of the sample chamber and an electro-optical sensor responsive to IR energy is disposed at an opposite end of the chamber. The respiratory gas analyzer also includes gas flow paths and valving for carrying out lung capacity and lung diffusion tests.

Abstract: The embodiments relate to generating a 2D projection image of a vascular system of a body region of interest, including: (1) acquiring a 3D dataset of the body region of interest, (2) acquiring at least one 2D projection image of the body region of interest (S3), (3) generating a modified 3D dataset by eliminating vessels whose size exceeds a predetermined limit value, (4) normalizing the 2D projection image using projection data of the modified 3D dataset, (5) eliminating vessel projections in the normalized 2D projection image whose size exceeds a predetermined limit value, (6) interpolating the areas of the 2D projection image in which the vessel projections have been eliminated, and (7) denormalizing the normalized and interpolated 2D projection image using projection data of the modified 3D dataset.

Abstract: A system, method and device for brachytherapy treatment verification is described herein. The verification may be in real time and may provide verification of one or more of dose, source position, dwell time and source activity. In one embodiment the invention provides a method for verifying a brachytherapy radiation treatment including processing a distribution of exposure to a brachytherapy radiation source of a two dimensional imaging array to determine a region of high exposure; obtaining one or more distribution of exposure profiles through the region of high exposure; determining a region of high value in the one or more distribution of exposure profiles; and using the determined region of high exposure and/or high value to calculate one or more brachytherapy radiation source position and/or one or more brachytherapy radiation source distance to thereby verify at least a part of the brachytherapy radiation treatment.

Abstract: A magnetic resonance imaging apparatus according to an embodiment is a magnetic resonance imaging apparatus that performs a contrast medium imaging, comprising a time management part that measures and manages a lapse time after injection of a contrast medium, a setting part that sets a start time of a second-half imaging in the form of a lapse time after injection of contrast medium, the second-half imaging being performed a predetermined idle time after a first-half imaging and the first-half imaging being performed after injection of the contrast medium, and a display part that displays at least the lapse time measured by the time management part and the start time set by the setting part.